The additional liquidity will support both the continued development of Trinity Biotech’s innovative continuous glucose monitoring (CGM) technology and the Company Trinity Biotech’s patented ...

Pathway Triangle’s King Street Properties confirmed that it has leased manufacturing space in Morrisville. What to know.

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC ...

Over the last year, Trinity Biotech Plc share price has been traded in a range of 0.2489, hitting a high of 0.8499, and a low of 0.601. Trinity Biotech Plc is listed on the CBOE trading with ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Tucson-based biotech firm HTG Molecular Diagnostics has filed for Chapter 11 bankruptcy protection, with plans to continue operations as it works out a plan to pay its debts. The company ...

“And God said, Let us make man in our image, after our likeness: and let them have dominion over the fish of the sea, and over the fowl of the air, and over the cattle, and over all the earth ...

Novo Holdings led a $92 million Series A investment in Kivu Biosciences, a San Francisco biotech focusing on the development of antibody-drug conjugates for solid tumours. Like other ADC start-ups ...

J&J's announcement came just hours after GSK confirmed it had agreed a $1 billion deal to buy cancer biotech IDRx and its KIT inhibitor for gastrointestinal stromal tumours (GIST). If completed ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...